BioSyent Announces Renewal of Normal Course Issuer Bid
MISSISSAUGA, Ontario, Dec. 15, 2025 (GLOBE NEWSWIRE) — BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that the TSX Venture Exchange ("TSX-V") has accepted the Company's Notice of Intention to Make a Normal Course Issuer Bid
(Financial Post, 2025-12-15T21:33:08Z)